The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.
14 hepatitis B vaccine recipients who showed high titers of anti-hepatitis B surface antibodies in serum after booster immunization with a polyvalent hepatitis B surface antigen vaccine that contained trace amounts of hepatitis B virus (HBV) preS1 and preS2 envelope antigens were studied for their i...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1989
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329792/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2529268/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114299 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
